Stemline Therapeutics (STML) Tops Q3 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. TMUS
9. SPY
10. SBUX

Go back to Stemline Therapeutics (STML) Tops Q3 EPS by 5c

Stemline Therapeutics to Participate in the Barclays Select Series Symposium

November 10, 2014 7:00 AM EST

NEW YORK, Nov. 10, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML) announced today that Stemline will participate in the Barclays Select Series Symposium taking place November 12-13, 2014. The symposium will take place at Barclays' offices in New York, NY, and "will bring together a diverse group of Small & Mid Cap companies that hold strong investment appeal based on their fundamental prospects."

About Stemline Therapeutics

Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics that target both cancer stem cells (CSCs) and tumor bulk. Stemline is currently... More